Sonic Healthcare Ltd
SHL: XASX (AUS)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| q& | LOCK|^$%d | LOCK|wS@YyX |
Sonic Healthcare Earnings: Shares Undervalued as Market Demands Faster Margin Turnaround
Sonic Healthcare's fiscal 2025 EBITDA rose 9% on 5% organic sales growth and underlying EBITDA margins expanding 40 basis points to 18%. Fiscal 2026 EBITDA guidance implies 8% growth at the midpoint in constant-currency, disappointing the market with shares down over 12%.
